People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,543.50GBp
31 Oct 2014
Price Change (% chg)

43.50p (+0.97%)
Prev Close
4,500.00p
Open
4,550.00p
Day's High
4,600.00p
Day's Low
4,517.50p
Volume
3,026,437
Avg. Vol
2,630,727
52-wk High
4,946.41p
52-wk Low
3,237.50p

Search Stocks

Vadera, Shriti 

Brief Biography

The Right Honourable Baroness Shriti Vadera is Non-Executive Independent Director of AstraZeneca PLC., since January 1, 2011. Shriti has experience of emerging markets, and knowledge of global finance and public policy. She is a Non-Executive Director of BHP Billiton Plc and BHP Billiton Limited. She advises funds, governments and companies and has recently undertaken a number of international assignments including advising the Republic of Korea as Chair of the G20, the government of Dubai on the restructuring of Dubai World, Temasek Holdings, Singapore on strategy and Allied Irish Banks on restructuring and European policy. She was Minister in the UK government from 2007 to 2009, most latterly in the Cabinet Office and Business Department, working on the government’s response to the financial crisis. From 1999 to 2007, she was on the Council of Economic Advisers, HM Treasury focusing on business and international economic issues. Prior to that she spent 14 years in investment banking with S G Warburg/ UBS in banking, project finance and corporate finance specialising in emerging markets.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

540,000

Pascal Soriot

3,344,000

Marc Dunoyer

296,000

Ruud Dobber

--

Caroline Hempstead

--

Paul Hudson

--
As Of 30 Dec 2013
Search Stocks